NCCN 2012 Webinar Series: Sarcomas™: Management of Localized Soft Tissue Sarcomas: The Role of Neoadjuvant and Adjuvant Systemic Therapy
This webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Sarcomas (Soft Tissue and Bone). Participants will learn how to implement the NCCN Guidelines recommendations into their practice and gain a clear understanding of the most up-to-date treatment recommendations for these cancers. As research continues in these areas and new information emerges, it is critical that clinicians are kept up-to-date and informed. These webinars will communicate the NCCN Guidelines in a direct and interactive way to community oncologists and other clinical professionals.
This educational program is designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.
Following this webinar, participants should be able to:
- Discuss the evidence supporting the use of preoperative and postoperative chemotherapy and chemoradiation in the management of patients with STS
- Summarize the clinical evidence supporting the use of preoperative and postoperative imatinib for patients with GISTs
- Describe the criteria recommended for the selection of patients for neoadjuvant and adjuvant systemic therapy in patients with STS and GISTs
Shreyaskumar Patel, MD
The University of Texas MD Anderson Cancer Center
- 1.00 Participation
- 1.00 Nurse
- 1.00 Pharmacist
- 1.00 Physician